Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]

Bibliographic Details
Main Authors: Pradip De, Yuling Sun, Jennifer H. Carlson, Lori S. Friedman, Brian R. Leyland-Jones, Nandini Dey
Format: Article
Language:English
Published: Elsevier 2014-04-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558614000311
_version_ 1818911385061425152
author Pradip De
Yuling Sun
Jennifer H. Carlson
Lori S. Friedman
Brian R. Leyland-Jones
Nandini Dey
author_facet Pradip De
Yuling Sun
Jennifer H. Carlson
Lori S. Friedman
Brian R. Leyland-Jones
Nandini Dey
author_sort Pradip De
collection DOAJ
first_indexed 2024-12-19T22:57:51Z
format Article
id doaj.art-58c678585f3a4804baf55a9aee07b1bb
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-12-19T22:57:51Z
publishDate 2014-04-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-58c678585f3a4804baf55a9aee07b1bb2022-12-21T20:02:35ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022014-04-0116437510.1016/j.neo.2014.03.012Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]Pradip DeYuling SunJennifer H. CarlsonLori S. FriedmanBrian R. Leyland-JonesNandini Deyhttp://www.sciencedirect.com/science/article/pii/S1476558614000311
spellingShingle Pradip De
Yuling Sun
Jennifer H. Carlson
Lori S. Friedman
Brian R. Leyland-Jones
Nandini Dey
Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
Neoplasia: An International Journal for Oncology Research
title Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
title_full Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
title_fullStr Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
title_full_unstemmed Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
title_short Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
title_sort erratum to doubling down on the pi3k aktmtor pathway enhances the antitumor efficacy of parp inhibitor in triple negative breast cancer model beyond brca ness neoplasia 16 2014 43 72
url http://www.sciencedirect.com/science/article/pii/S1476558614000311
work_keys_str_mv AT pradipde erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
AT yulingsun erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
AT jenniferhcarlson erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
AT lorisfriedman erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
AT brianrleylandjones erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
AT nandinidey erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372